资讯

MedPage Today on MSN5 天
Isturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes?
Orforglipron, a daily GLP-1 receptor agonist pill, lowered HbA1c by up to 1.6% and body weight by 7.9% in a phase III trial ...